Johnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire ...

Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest drugs market. Join the conversation, on Tuesday 28th January ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement ...

Annovis Bio Inc. ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

The Savannah Police Department is looking for a missing man who suffers from dementia. Clyde Thornhill has reportedly been ...

In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

I want to take this opportunity to thank you for your continued trust and support in Nexalin Technology. Our progress over the past year reflects our commitment to addressing the global mental health ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.